Paper42321945
Amnion-derived mesenchymal stem cells attenuate anti-GBM glomerulonephritis via regulation of neutrophil CD44 expression.
Nozaki T and 18 others. Stem Cell Res Ther, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Amnion-derived mesenchymal stem cells attenuate anti-GBM glomerulonephritis via regulation of neutrophil CD44 expression. Papers, record 42321945. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42321945
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Amnion-derived mesenchymal stem cells attenuate anti-GBM glomerulonephritis via regulation of neutrophil CD44 expression.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hyaluronan Receptors | Major topic |
| Mesenchymal Stem Cells | Major topic |
| Neutrophils | Major topic |
| Mesenchymal Stem Cell Transplantation | Major topic |
| Amnion | Major topic |
| Glomerulonephritis | Major topic |
| Anti-Glomerular Basement Membrane Disease | Major topic |
| Animals | |
| Rats | |
| Humans | |
| Rats, Sprague-Dawley | |
| Male | |
| Disease Models, Animal |
Source PubMed
References55
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 17460140 | Mesenchymal stem cells prevent progressive experimental renal failure but maldifferentiate into glomerular adipocytes. | J Am Soc Nephrol | 2007 | https://conductscience.org/library/papers/17460140 | PubMed |
| 2 | 3501499 | T-cells and macrophages in rapidly progressive glomerulonephritis: clinicopathologic correlations. | Kidney Int | 1987 | https://conductscience.org/library/papers/3501499 | PubMed |
| 3 | 20583996 | Mesenchymal stromal cells improve renal injury in anti-Thy 1 nephritis by modulating inflammatory cytokines and scatter factors. | Clin Sci (Lond) | 2011 | https://conductscience.org/library/papers/20583996 | PubMed |
| 4 | 6527375 | Experimental autoimmune glomerulonephritis with pulmonary hemorrhage in rats. The dose-effect relationship of the nephritogenic antigen from bovine glomerular basement membrane. | J Clin Lab Immunol | 1984 | https://conductscience.org/library/papers/6527375 | PubMed |
| 5 | 12969182 | Anti-glomerular basement membrane disease. | Kidney Int | 2003 | https://conductscience.org/library/papers/12969182 | PubMed |
| 6 | 8995722 | Th1 responsiveness to nephritogenic antigens determines susceptibility to crescentic glomerulonephritis in mice. | Kidney Int | 1997 | https://conductscience.org/library/papers/8995722 | PubMed |
| 7 | 20844023 | Human marrow-derived mesenchymal stromal cells decrease cisplatin renotoxicity in vitro and in vivo and enhance survival of mice post-intraperitoneal injection. | Am J Physiol Renal Physiol | 2010 | https://conductscience.org/library/papers/20844023 | PubMed |
| 8 | 28515156 | Anti-Glomerular Basement Membrane Disease. | Clin J Am Soc Nephrol | 2017 | https://conductscience.org/library/papers/28515156 | PubMed |
| 9 | 39411720 | Cluster of differentiation-44 as a novel biomarker of lupus nephritis and its role in kidney inflammation and fibrosis. | Front Immunol | 2024 | https://conductscience.org/library/papers/39411720 | PubMed |
| 10 | 20667782 | Neutrophils: game changers in glomerulonephritis? | Trends Mol Med | 2010 | https://conductscience.org/library/papers/20667782 | PubMed |
| 11 | 11805163 | Anti-CD8 monoclonal antibody therapy is effective in the prevention and treatment of experimental autoimmune glomerulonephritis. | J Am Soc Nephrol | 2002 | https://conductscience.org/library/papers/11805163 | PubMed |
| 12 | 9067898 | Antibody independent crescentic glomerulonephritis in mu chain deficient mice. | Kidney Int | 1997 | https://conductscience.org/library/papers/9067898 | PubMed |
| 13 | 23826305 | Therapeutic effects of human mesenchymal stem cells in Wistar-Kyoto rats with anti-glomerular basement membrane glomerulonephritis. | PLoS One | 2013 | https://conductscience.org/library/papers/23826305 | PubMed |
| 14 | 23676112 | Mesenchymal stromal cell characteristics vary depending on their origin. | Stem Cells Dev | 2013 | https://conductscience.org/library/papers/23676112 | PubMed |
| 15 | 31730279 | Immune modulation by mesenchymal stem cells. | Cell Prolif | 2020 | https://conductscience.org/library/papers/31730279 | PubMed |
| 16 | 16790513 | Transplanted mesenchymal stem cells accelerate glomerular healing in experimental glomerulonephritis. | J Am Soc Nephrol | 2006 | https://conductscience.org/library/papers/16790513 | PubMed |
| 17 | 20739390 | Allogenic fetal membrane-derived mesenchymal stem cells contribute to renal repair in experimental glomerulonephritis. | Am J Physiol Renal Physiol | 2010 | https://conductscience.org/library/papers/20739390 | PubMed |
| 18 | 12815141 | Alport's syndrome, Goodpasture's syndrome, and type IV collagen. | N Engl J Med | 2003 | https://conductscience.org/library/papers/12815141 | PubMed |
| 19 | 16624930 | T cells in crescentic glomerulonephritis. | J Am Soc Nephrol | 2006 | https://conductscience.org/library/papers/16624930 | PubMed |
| 20 | 35249813 | The membrane receptor CD44: novel insights into metabolism. | Trends Endocrinol Metab | 2022 | https://conductscience.org/library/papers/35249813 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42321945
GET https://conductscience.org/api/papers/v1/42321945/references?page=2